ASP Isotopes Inc. (ASPI) Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs

ASP Isotopes Inc. Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs

ASP Isotopes Inc. (ASPI) had Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs of $584.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-10.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross

us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts · last filed 2026-04-10

• 2025-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $584.00K.
• 2024-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $34.00K; Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs as first filed $33.76K.
• 2023-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $31.62K.
• 2022-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $50.29K.